Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker MLYS
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 3,542 | $78.1K | 10b5-1 | Oct 13, 2026 | — | Form 144 ↗ |
| Sep 30, 2026 | Jon Congleton Officer, Director | MLYS Mineralys Therapeutics, Inc. | 75,000 | $1.9M | 10b5-1 | Sep 30, 2026 | — | Form 144 ↗ |
| Sep 22, 2026 | Catalys Pacific Fund LP Director | MLYS Mineralys Therapeutics, Inc. | 104,320 | $3.0M | — | Sep 22, 2026 | — | Form 144 ↗ |
| Sep 21, 2026 | Warren Eric Officer | MLYS Mineralys Therapeutics, Inc. | 7,438 | $209.1K | 10b5-1 | Sep 21, 2026 | Form 4 ↗ 1 day later · 7,438 shares | Form 144 ↗ |
| Sep 17, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 417 | $11.7K | 10b5-1 | Sep 17, 2026 | — | Form 144 ↗ |
| Sep 15, 2026 | Karydas Daphne Officer | MLYS Mineralys Therapeutics, Inc. | 3,000 | $85.7K | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 2 days later · 3,000 shares | Form 144 ↗ |
| Sep 14, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 7,709 | $216.9K | 10b5-1 | Sep 14, 2026 | — | Form 144 ↗ |
| Sep 9, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 2,171 | $67.0K | 10b5-1 | Sep 9, 2026 | — | Form 144 ↗ |
| Aug 21, 2026 | Warren Eric Officer | MLYS Mineralys Therapeutics, Inc. | 7,437 | $193.2K | 10b5-1 | Aug 21, 2026 | Form 4 ↗ 4 days later · 7,437 shares | Form 144 ↗ |
| Aug 17, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 417 | $10.6K | 10b5-1 | Aug 17, 2026 | — | Form 144 ↗ |
| Aug 13, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 14,056 | $372.2K | 10b5-1 | Aug 13, 2026 | Form 4 ↗ -1 days later · 2,170 shares | Form 144 ↗ |
| Aug 10, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 2,170 | $58.8K | 10b5-1 | Aug 10, 2026 | Form 4 ↗ 2 days later · 2,170 shares | Form 144 ↗ |
| Jul 21, 2026 | Warren Eric Officer | MLYS Mineralys Therapeutics, Inc. | 7,438 | $199.9K | 10b5-1 | Jul 21, 2026 | Form 4 ↗ 2 days later · 7,438 shares | Form 144 ↗ |
| Jul 17, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 416 | $11.0K | 10b5-1 | Jul 17, 2026 | Form 4 ↗ 3 days later · 416 shares | Form 144 ↗ |
| Jul 15, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 6,349 | $169.0K | 10b5-1 | Jul 15, 2026 | Form 4 ↗ same day · 20,407 shares | Form 144 ↗ |
| Jul 14, 2026 amended | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 14,058 | $387.7K | 10b5-1 | Jul 13, 2026 | Form 4 ↗ 1 day later · 20,407 shares | Form 144/A ↗ |
| Jul 13, 2026 | Jon Congleton Officer, Director | MLYS Mineralys Therapeutics, Inc. | 10,700 | $291.4K | 10b5-1 | Jul 13, 2026 | Form 4 ↗ 2 days later · 10,700 shares | Form 144 ↗ |
| Jul 13, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 14,508 | $387.7K | 10b5-1 | Jul 13, 2026 | Form 4 ↗ 2 days later · 20,407 shares | Form 144 ↗ |
| Jul 9, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 2,171 | $65.8K | 10b5-1 | Jul 9, 2026 | Form 4 ↗ 1 day later · 2,171 shares | Form 144 ↗ |
| Jun 30, 2026 | Jon Congleton Officer | MLYS Mineralys Therapeutics, Inc. | 75,000 | $2.0M | 10b5-1 | Jun 30, 2026 | Form 4 ↗ same day · 75,000 shares | Form 144 ↗ |
| Jun 29, 2026 | Warren Eric Officer | MLYS Mineralys Therapeutics, Inc. | 104,124 | $2.7M | 10b5-1 | Jun 26, 2026 | Form 4 ↗ 24 days later · 7,438 shares | Form 144 ↗ |
| Jun 17, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 4,584 | $114.6K | 10b5-1 | Jun 17, 2026 | Form 4 ↗ same day · 14,474 shares | Form 144 ↗ |
| Jun 17, 2026 | Karydas Daphne Officer | MLYS Mineralys Therapeutics, Inc. | 3,000 | $75.0K | 10b5-1 | Jun 17, 2026 | Form 4 ↗ same day · 3,000 shares | Form 144 ↗ |
| Jun 15, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 9,890 | $235.5K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 2 days later · 14,474 shares | Form 144 ↗ |
| Jun 12, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 6,349 | $151.9K | 10b5-1 | Jun 12, 2026 | Form 4 ↗ same day · 8,519 shares | Form 144 ↗ |
| Jun 10, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 2,170 | $54.3K | 10b5-1 | Jun 10, 2026 | Form 4 ↗ 2 days later · 8,519 shares | Form 144 ↗ |
| May 18, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 417 | $11.5K | 10b5-1 | May 18, 2026 | Form 4 ↗ 1 day later · 417 shares | Form 144 ↗ |
| May 13, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 14,056 | $401.8K | 10b5-1 | May 13, 2026 | Form 4 ↗ same day · 22,575 shares | Form 144 ↗ |
| May 12, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 6,348 | $186.3K | 10b5-1 | May 12, 2026 | Form 4 ↗ 1 day later · 22,575 shares | Form 144 ↗ |
| May 11, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 2,171 | $64.5K | 10b5-1 | May 11, 2026 | Form 4 ↗ 2 days later · 22,575 shares | Form 144 ↗ |
| Apr 17, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 416 | $13.0K | 10b5-1 | Apr 17, 2026 | Form 4 ↗ 4 days later · 416 shares | Form 144 ↗ |
| Apr 15, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 6,348 | $175.6K | 10b5-1 | Apr 15, 2026 | Form 4 ↗ same day · 20,406 shares | Form 144 ↗ |
| Apr 13, 2026 | Jon Congleton Officer | MLYS Mineralys Therapeutics, Inc. | 15,730 | $422.0K | 10b5-1 | Apr 13, 2026 | Form 4 ↗ 2 days later · 15,730 shares | Form 144 ↗ |
| Apr 13, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 14,058 | $373.1K | 10b5-1 | Apr 13, 2026 | Form 4 ↗ 2 days later · 20,406 shares | Form 144 ↗ |
| Apr 9, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 2,170 | $59.4K | 10b5-1 | Apr 9, 2026 | Form 4 ↗ 4 days later · 2,170 shares | Form 144 ↗ |
| Mar 31, 2026 | Karydas Daphne Officer | MLYS Mineralys Therapeutics, Inc. | 3,000 | $75.0K | 10b5-1 | Mar 31, 2026 | Form 4 ↗ 2 days later · 3,000 shares | Form 144 ↗ |
| Mar 31, 2026 | Jon Congleton Officer | MLYS Mineralys Therapeutics, Inc. | 75,000 | $2.0M | 10b5-1 | Mar 31, 2026 | Form 4 ↗ 2 days later · 75,000 shares | Form 144 ↗ |
| Mar 17, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 417 | $10.7K | 10b5-1 | Mar 17, 2026 | Form 4 ↗ same day · 417 shares | Form 144 ↗ |
| Mar 13, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 14,058 | $369.2K | 10b5-1 | Mar 13, 2026 | Form 4 ↗ 3 days later · 20,406 shares | Form 144 ↗ |
| Mar 12, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 6,348 | $173.7K | 10b5-1 | Mar 12, 2026 | Form 4 ↗ 4 days later · 20,406 shares | Form 144 ↗ |
| Mar 9, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 2,171 | $58.3K | 10b5-1 | Mar 9, 2026 | Form 4 ↗ 1 day later · 2,171 shares | Form 144 ↗ |
| Feb 17, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 417 | $11.5K | 10b5-1 | Feb 17, 2026 | Form 4 ↗ same day · 417 shares | Form 144 ↗ |
| Feb 13, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 14,055 | $385.7K | 10b5-1 | Feb 13, 2026 | Form 4 ↗ same day · 20,404 shares | Form 144 ↗ |
| Feb 12, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 6,349 | $184.1K | 10b5-1 | Feb 12, 2026 | Form 4 ↗ 1 day later · 20,404 shares | Form 144 ↗ |
| Feb 9, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 2,171 | $65.6K | 10b5-1 | Feb 9, 2026 | Form 4 ↗ 2 days later · 2,171 shares | Form 144 ↗ |
| Jan 20, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 416 | $13.4K | 10b5-1 | Jan 20, 2026 | Form 4 ↗ same day · 416 shares | Form 144 ↗ |
| Jan 14, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 11,367 | $370.6K | 10b5-1 | Jan 14, 2026 | Form 4 ↗ 1 day later · 19,076 shares | Form 144 ↗ |
| Jan 13, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 7,709 | $252.5K | 10b5-1 | Jan 13, 2026 | Form 4 ↗ 2 days later · 19,076 shares | Form 144 ↗ |
| Jan 12, 2026 | Rodman David Malcom Officer | MLYS Mineralys Therapeutics, Inc. | 6,348 | $205.1K | 10b5-1 | Jan 12, 2026 | Form 4 ↗ 1 day later · 8,518 shares | Form 144 ↗ |
| Jan 12, 2026 | Levy Adam Scott Officer | MLYS Mineralys Therapeutics, Inc. | 10,758 | $345.7K | 10b5-1 | Jan 12, 2026 | Form 4 ↗ 1 day later · 10,758 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:02 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances